Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease

Published:2010-06-01 Issue:3 Volume:52 Page:913-924
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Neuschwander-Tetri Brent A.,Clark Jeanne M.,Bass Nathan M.,Van Natta Mark L.,Unalp-Arida Aynur,Tonascia James,Zein Claudia O.,Brunt Elizabeth M.,Kleiner David E.,McCullough Arthur J.,Sanyal Arun J.,Diehl Anna Mae,Lavine Joel E.,Chalasani Naga,Kowdley Kris V.,

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.23784/fullpdf

Reference41 articles.

1. The epidemiology of nonalcoholic fatty liver disease in adults;Clark;J Clin Gastroenterol,2006

2. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference;Neuschwander-Tetri;HEPATOLOGY,2003

3. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive;Wieckowska;Semin Liver Dis,2008

4. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values;Mofrad;HEPATOLOGY,2003

5. Brief communication: clinical implications of short-term variability in liver function test results;Lazo;Ann Intern Med,2008

Cited by 397 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The steatosis-associated fibrosis estimator (SAFE) outperformed the FIB-4 score in screening the population for liver disease;Annals of Hepatology;2024-09

2. Exploring the Pathogenesis of NAFLD: A Study of the Correlation of Gut Microbes and Metabolites in Humanized Mouse Gut Microbiota;2024-08-17

3. NAFLD (MASLD)/NASH (MASH): Does It Bother to Label at All? A Comprehensive Narrative Review;International Journal of Molecular Sciences;2024-08-02

4. Increases and decreases in liver stiffness measurement are independently associated with the risk of liver-related events in NAFLD;Journal of Hepatology;2024-05

5. Benchmarking clinical risk prediction algorithms with ensemble machine learning for the noninvasive diagnosis of liver fibrosis in NAFLD;Hepatology;2024-04-30